Het Wenckebach Institut
Het Wenckebach Skillscenter
OOR Noord- en Oostnederland
International conferences



Committee and Faculty
Call for abstracts
Costs and registration
Practical information
Patiëntenmiddag 10 mei
Daily Pictures Congress



XIII International Symposium on Amyloidosis

From misfolded proteins to well-designed treatment

Registration is closed - see 'Costs and registration'

May 6-10, 2012

University Medical Center Groningen


Dear amyloid-friend,

In 1967 Professor Enno Mandema hosted the first International Symposium on Amyloidosis in Groningen. We are proud to announce that, almost 45 years later, Groningen will be again the venue of the XIIIth Symposium.

This symposium will focus on basic and translational research in the systemic amyloidoses. The systemic amyloidoses are rare diseases caused by clonal immunoglobulin light chains, mutant and wild type transthyretin proteins, serum amyloid A protein, and β2microglobulin that cause disease in all organ systems but most frequently in kidney, heart, gastrointestinal tract and nervous system. The systemic amyloidoses also include diseases caused by a number of inherited mutant proteins, that lead to late onset amyloid fibril deposition in renal, gastrointestinal, and neurologic systems, including the proteins: apolipoprotein AI, apolipoprotein AII, fibrinogen, lysozyme, and gelsolin.

The scientific program will include oral presentations and posters on the process of fibrillogenesis, mechanisms of cell damage and tissue toxicity, emerging diagnostics, and innovative therapeutics. These are current, cutting edge research topics in the systemic amyloidoses. This symposium will encourage a training environment for junior investigators and trainees. Their presentations will be encouraged. All sessions will provide ample time for discussion after each presentation. We hope to bring together senior investigators, junior investigators, and trainees of all disciplines of science and medicine from a large world-wide community of amyloid researchers.

On behalf of the organizing committee,

Bouke Hazenberg

Ingrid van Gameren

Johan Bijzet
Groningen Unit for Amyloidosis Research & Development (GUARD)



Naar boven